
United States · Medical devices startup
Neuspera Medical Inc.
Funding reportedLast round: Series D
Neuspera Medical Inc.
is a medical technology company based in San Jose, California, founded in 2013. The company specializes in developing minimally invasive implantable neuromodulation devices designed to treat chronic conditions. Its flagship product is the first integrated sacral neuromodulation (iSNM) system for urinary urge incontinence (UUI), which received FDA approval in June 2025. Neuspera's core innovation is its Mid-Field Powering Technology, enabling battery-free, ultra-miniaturized implants that can be placed deeper in the body with less invasive procedures. The Neuspera Implantable Sacral Neuromodulation System consists of a minimally invasive implant and an external wearable transmitter that delivers targeted nerve stimulation to improve bladder control. The company aims to expand its platform to address various chronic conditions, including epilepsy and heart failure, while focusing on providing adaptable treatment options for patients.
Funding, as reported
From Neuspera Medical Inc.'s own website and the SEC filings it signed: 4 on the team.
On the board, as filediAdam M. FineArt M. TaylorImran M. EbaLori M. HuMudit K. Jain
What they build
Known for
health careperipheral nerve stimulationneurostimulationmanufacturingwireless energy systemsminimally invasive neuromodulationneural interface technologyacute clinical studiesneurostimulation technologyremotely adjustable treatmentenergy transfer technologywireless chargingfda regulatory approvalmedical implant technologyuui treatmentpatient empowerment
Built with from their website
parallax.jsWordPress.orgFont AwesomeCloudFlareViewport MetaWP EngineApple Business ManagerOWL CarouselPriority HintsMicrosoft Exchange
SalesforceMySQLPrimeNGMicrosoft 365 Apps & ServicesMobile FriendlyBootstrapOpen GraphjQuery
Add your raise, your deck and your story, and put Neuspera Medical Inc. in front of investors. Or tell us what we have wrong.